Literature DB >> 15769866

Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat.

Adebayo O Oyekan1.   

Abstract

We recently demonstrated that endothelin-1-induced medullary vasodilation despite a potent cortical vasoconstriction in the rat kidney may be accounted for by 20-hydroxyeicosatetraenoic acid (20-HETE) production. This study characterized the effects of 20-HETE and its metabolites, 20-hydroxy prostaglandin E(2) (20-OH PGE(2)) and 20-hydroxy prostaglandin F(2alpha) (20-OH PGF(2alpha)), and the contribution of nitric oxide (NO) and prostanoids to the changes evoked in cortical blood flow (CBF) and medullary blood flow (MBF). We tested the hypothesis that 20-HETE produces qualitatively different regional hemodynamic effects in the kidney with 20-OH PGF(2alpha) or 20-OH PGE(2), accounting for the vasoconstriction or vasodilation, respectively, in the cortex and medulla. Renal intra-arterial infusion of 1, 2.5, 5, and 10 ng/min 20-HETE decreased CBF by 10 +/- 3, 24 +/- 4, 40 +/- 7, and 58 +/- 9 perfusion units (PU), respectively, but increased MBF by 4 +/- 2, 16 +/- 4, 27 +/- 3, and 41 +/- 10 PU, respectively. 20-OH PGF(2alpha) mimics the effects of 20-HETE, as did PGF(2alpha). However, 20-OH PGE(2) increased both CBF and MBF, as did PGE(2). Indomethacin (5 mg/kg) blunted the effects of 20-HETE but not that of 20-OH PGE(2) and 20-OH PGF(2alpha). However, SQ29548 ([1S-[1alpha,2alpha(Z),3alpha,4alpha]]-7-[3[[2-[(phenylamino)carbonyl[hydrazino]methyl]-7-oxabicyclo]2.2.1]hept-2-yl]-5-heptenoic acid) (0.1 mg/kg), a prostaglandin H(2)/thromboxane A(2) receptor antagonist, blunted the cortical and medullary hemodynamic effects elicited by 20-HETE, 20-OH PGE(2), 20-OH PGF(2alpha), and PGF(2alpha) but not PGE(2). N(omega)-L-nitro arginine methyl ester (5 mg/kg), the inhibitor of NO synthase, exacerbated the cortical constrictor effects of 20-HETE and 20-OH PGF(2alpha) without affecting the medullary perfusion produced by 20-HETE or its metabolites. These findings suggest that 20-HETE, through its hydroxyl metabolites, produced differential effects in the kidney. The medullary perfusion appears to be independent of NO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769866     DOI: 10.1124/jpet.104.080218

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury.

Authors:  Kevin R Regner; Anna Zuk; Scott K Van Why; Brian D Shames; Robert P Ryan; John R Falck; Vijay L Manthati; Meghan E McMullen; Steven R Ledbetter; Richard J Roman
Journal:  Kidney Int       Date:  2008-12-03       Impact factor: 10.612

2.  Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.

Authors:  Yoshikazu Muroya; Fan Fan; Kevin R Regner; John R Falck; Michael R Garrett; Luis A Juncos; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

Review 3.  Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury.

Authors:  Kevin R Regner; Richard J Roman
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

4.  20-HETE in acute kidney injury.

Authors:  Richard J Roman; Talha Akbulut; Frank Park; Kevin R Regner
Journal:  Kidney Int       Date:  2011-01       Impact factor: 10.612

5.  20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.

Authors:  Chan-Jung Liang; Ching-Ping Tseng; Chuen-Mao Yang; Yunn-Hwa Ma
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 6.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

7.  20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT/GSK-3β/Glut2 pathway.

Authors:  Bijun Zhang; Guangrui Lai; Jingjing Wu; Ru Sun; Runhong Xu; Xianghong Yang; Yafei Qi; Yanyan Zhao
Journal:  Endocrine       Date:  2016-08-27       Impact factor: 3.633

8.  Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.

Authors:  Yi Zhang; Md Nasrul Hoda; Xuan Zheng; Weiguo Li; Pengcheng Luo; Krishna Rao Maddipati; Tsugio Seki; Adviye Ergul; Mong-Heng Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

9.  20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

Authors:  Guangrui Lai; Jingjing Wu; Xiaoliang Liu; Yanyan Zhao
Journal:  Mol Endocrinol       Date:  2012-08-23

10.  20-HETE increases renal sympathetic nerve activity via activation of chemically and mechanically sensitive muscle afferents.

Authors:  Zhaohui Gao; Satoshi Koba; Lawrence Sinoway; Jianhua Li
Journal:  J Physiol       Date:  2008-03-27       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.